TELA Bio to Participate in the Jefferies Global Healthcare Conference
May 25 2023 - 6:00AM
TELA Bio, Inc. ("TELA"), a commercial-stage medical technology
company focused on providing innovative soft-tissue reconstruction
solutions that optimize clinical outcomes by prioritizing the
preservation and restoration of the patient’s own anatomy, today
announced that the Company will participate in the Jefferies Global
Healthcare Conference on Wednesday, June 7th, 2023.
TELA’s management is scheduled to present at the
Jefferies Global Healthcare Conference at 12:30 pm ET on June 7th,
2023. Interested parties can access the live and archived webcast
at ir.telabio.com.
About TELA Bio, Inc.
TELA Bio, Inc. (NASDAQ: TELA) is a commercial-stage
medical technology company focused on providing innovative
technologies that optimize clinical outcomes by prioritizing the
preservation and restoration of the patient’s own anatomy. The
Company is committed to providing surgeons with advanced,
economically effective soft-tissue reconstruction solutions that
leverage the patient’s natural healing response while minimizing
long-term exposure to permanent synthetic materials. For more
information, visit www.telabio.com.
Investor ContactGreg
Chodaczek347-620-7010ir@telabio.com
TELA Bio (NASDAQ:TELA)
Historical Stock Chart
From Apr 2024 to May 2024
TELA Bio (NASDAQ:TELA)
Historical Stock Chart
From May 2023 to May 2024